• Three distinguishable clinical forms of MLD found

Bioanalytical

Three distinguishable clinical forms of MLD found

Jan 30 2012

A study of five out of 200 patients presenting behavioural abnormalities and a progressive mental deterioration has found three distinguishable clinical forms of Metachromatic leukodystrophy (MLD).

The results found two patients to be suffering from a late-infantile form of MLD, one case of the juvenile form of MLD, along with the two patients with adult-type of MLD. This showed that magnetic resonance imaging (MRI) is required to guide the diagnosis of MLD patients. Biochemical investigations must also be used to confirm the results, based on the measurement of arylsulfatase A (ASA) activity and the excess of sulfatide showed in the sulfatiduria.

It was revealed from the study that there was clearly three distinguishable clinical forms of MLD. One presented in the juvenile form, two presented in late infantile form and the two other were presented in adult form.

All patients studied were first diagnosed by brain MRI evidencing a bilateral demyelination. ASA activity was then measured using P-nitrocathecol sulfate as substrate. Finally, sulfatiduria was performed using thin-layer chromatography using alpha-naphtol reagent.

Posted by Fiona Griffiths


Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

JASIS 2024

Sep 04 2024 Chiba, Tokyo, Japan

BMSS-BSPR Super Meeting 2024

Sep 04 2024 University of Warwick, Coventry, UK

View all events